Septic arthritis due to fungal infection is uncommon, but when it does occur it can have a devastating effect. Scedosporium prolificans is an emerging fungal pathogen that appears to have a predilection for bone and cartilaginous surfaces. This fungus is resistant to most commonly prescribed antifungal agents. We report the successful treatment of Scedosporium prolificans septic arthritis with a combination of surgery and new antifungal agents.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1445-2197.2006.03796.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!